Nomura Holdings’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Nomura Holdings’s Portfolio CADX Stock Details CADX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-57,738	Closed	-$523K	–	3097
2013 Q4	$523K	Sell	57,738 -7,753	-12%	-$56K	﹤0.01%	1259
2013 Q3	$412K	Sell	65,491 -12,233	-16%	-$77.8K	﹤0.01%	1493
2013 Q2	$533K	Buy	+77,724	New	+$541K	﹤0.01%	1278

Other funds holding CADX

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nomura Holdings's CADX Position: Q1 2014 in Review

Nomura Holdings sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 57,738 shares — an estimated $523K sold.

Nomura Holdings first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $533K in Q2 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

Nomura Holdings reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
Nomura Holdings sold 57,738 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $523K.
Nomura Holdings first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
Nomura Holdings's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $533K in Q2 2013.
3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Nomura Holdings's 13F filing for Q1 2014, filed 14 May 2014.